8. Malaisri C, Phuphuakrat A, Wibulpolprasert A, et al. A randomized controlled trial of sitafloxacin vs. ertapenem as a switch?therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichi...
[3] Harris PNA, Tambyah PA, Lye DC, et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinica...
45744581产ESBLs菌株血行感染:头孢菌素的经验性治疗疗效判断与MIC的相关性Bloodstream Infections Due to Extended-SpectrumBeta-Lactamase-Producing Escherichia coli and Klebsiella pneumo 20、niae:Risk Factors for Mortality and Treatment Outcome, with SpecialEmphasis on Antimicrobial Therapy. AAC. 2004, 48,(12)...
[8]Ten Doesschate T, Kuiper S, van Nieuwkoop C, et al. Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clin Infect Dis. 2022;75(2):221-229. doi:10.109...
[3] Harris PNA, Tambyah PA, Lye DC, et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial [published correction appears in JAMA. 2019 Jun 18;321(...
超广谱b-内酰胺酶(ESBL)是能水解头孢噻肟，头孢他 啶，头孢三嗪等第三代头孢菌素及氨曲南等单环类抗 生素，并介导细菌对这些抗生素耐药的b-内酰胺酶 超广谱b-内酰胺酶（ESBLs）是TEM-1/2或SHV-1经过1～4个氨基酸的突变而形成的 所有ESBLS其编码基因都在质粒上，DNA大小不等，23kbs~100...
产ESBLs肠杆菌科细菌感染以及治疗 社区革兰阴性菌感染肠杆菌科细菌 2%1%1%2%4%6% 8% >70% 46% E.coli Klebsiellaspp.Pseudomonasaeruginosa Enterobacterspp.,Serratiaspp.,andCitrobacterspp.Acinetobacterspp.Proteusmirabilis Indole-positiveProteusspp.13% Othernonfermenters Stenotrophomonasmaltophilia 17% Others Antimic...
Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. AAC. 2004, 48,(12),p. 4574–4581 38 学习交流PPT 产产ESBLs ESBLs菌株血行感染: 菌株血行感染:头孢菌素的经验性治 头孢菌素的经验性治...
18、ses&quantities of AB using for treatmentOf ESBL+patientsRecommended TherapyDrugs 2010;70(3)E倪语星,质粒介导的b-超广谱内酰胺酶的耐药性问题及检测中华医学检验杂志,1999,22(5):316l针对ESBL特性及耐药特点,推荐使用:碳青酶烯类抗生素(亚胺培南/西司他丁)b-内酰胺类/酶抑制剂(头孢哌酮/舒巴坦,哌拉...
[6] Ho P L,Chow K H, Lai E L, et al. Extended-spectrum-beta-lactamase-positive Escherichiacoli mainly adds to, rather than replaces,extended-spectrum-beta-lactamase-negative E. coli in causing bacteraemia inHong Kong, 2000-10[J]. J...